Zhang Yiting, Li Zhiwen, Li Hongtian, Jin Lei, Zhang Yali, Zhang Le, Liu Jufen, Ye Rongwei, Liu Jianmeng, Ren Aiguo
a Institute of Reproductive and Child Health/Ministry of Health Key Laboratory of Reproductive Health , Peking University , Beijing , China.
b Haidian Maternal and Child Health Hospital , Beijing , China.
J Obstet Gynaecol. 2018 Jan;38(1):32-37. doi: 10.1080/01443615.2017.1325454. Epub 2017 Jul 25.
The aim was to examine the relationship between maternal haemoglobin (Hb) concentrations and risk of preterm birth by secondary analysis of data from a randomised controlled trial. This analysis included 10,430 women who were at least 20 years old and no more than 20 weeks of gestation. Results revealed neither first- nor second-trimester Hb concentrations were associated with the risk of preterm births. However, the risk of preterm birth increased when the Hb level was low (<130 g/L) in the first but high (≥130 g/L) in the second trimester, regardless of supplement type (iron-containing: AOR: 2.26, 95% CI: 1.37-3.73; non-iron-containing: AOR: 2.16, 95% CI: 1.11-4.21). In conclusion, maternal Hb concentrations were not associated with the risk of preterm birth. A low-Hb level in the first trimester but coupled with a high Hb level in the second was associated with an elevated risk of preterm birth. Impact statement What is already known on this subject: The relationship between maternal Hb concentration and preterm birth remains inconclusive. Some studies have shown an association between a low- or a high-Hb level and an increased risk of preterm birth. Others have not found such an association. Yet others have shown a U-shaped relationship. What do the results of this study add: Overall, maternal Hb concentrations in first or second trimester were not statistically associated with the risk of preterm birth. However, women with a low Hb concentration in the first trimester together with a high Hb concentration in the second trimester had an increased risk of preterm birth, compared to women who had a higher Hb concentration in the first trimester that remained similar during the second trimester. What are the implications are of these findings for clinical practice and/or further research: Our finding helps identify mothers who are at risk of having a preterm delivery. Investigating the underlying clinical causes of the unfavourable change in Hb levels and close follow-up to these women may help improve birth outcomes.
目的是通过对一项随机对照试验的数据进行二次分析,研究孕妇血红蛋白(Hb)浓度与早产风险之间的关系。该分析纳入了10430名年龄至少20岁且妊娠不超过20周的女性。结果显示,孕早期和孕中期的Hb浓度均与早产风险无关。然而,无论补充剂类型如何(含铁:调整后比值比[AOR]:2.26,95%置信区间[CI]:1.37 - 3.73;不含铁:AOR:2.16,95% CI:1.11 - 4.21),当孕早期Hb水平低(<130 g/L)而孕中期高(≥130 g/L)时,早产风险会增加。总之,孕妇Hb浓度与早产风险无关。孕早期Hb水平低但孕中期Hb水平高与早产风险升高有关。影响声明关于该主题已有的了解:孕妇Hb浓度与早产之间的关系尚无定论。一些研究表明低Hb水平或高Hb水平与早产风险增加有关。其他研究则未发现这种关联。还有一些研究显示呈U形关系。本研究结果补充了什么:总体而言,孕早期或孕中期的孕妇Hb浓度与早产风险无统计学关联。然而,与孕早期Hb浓度较高且孕中期保持相似的女性相比,孕早期Hb浓度低且孕中期Hb浓度高的女性早产风险增加。这些发现对临床实践和/或进一步研究有何启示:我们的发现有助于识别有早产风险的母亲。调查Hb水平不利变化的潜在临床原因并对这些女性进行密切随访可能有助于改善分娩结局。